Corrigendum to "The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries" [Experimental Neurology, 283 (2016) 129-141]
Exp Neurol. 2023 Apr:362:114328.
doi: 10.1016/j.expneurol.2023.114328.
Epub 2023 Jan 25.
1 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address: AmalAbdel-Aziz@pharma.asu.edu.eg.
2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
3 National Center for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt.
4 Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt.